TRANSIRNA
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90272202
- Registration number
- 7342045
- Mark type
- Stylized text
- Filed
- 22 Oct 2020
- Published for opposition
- 16 Jan 2024
- Registered
- 02 Apr 2024
- Attorney of record
- Lenny R. Jiang
Goods and services
- Class 001 — Chemicals: preparations for gene recombination for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; preparations for nucleic acid for scientific or laboratory purposes; oligopeptides for use in the manufacture of cosmetics; peptide substrates for scientific purposes
- Class 005 — Pharmaceuticals: preparations for gene recombination for medical purposes; oligonucleotides for medical purposes; recombinant nucleic acid for medical purposes; nucleic acid for medical purposes; preparations for nucleic acid for medical purposes; medicated scalp treatments; medicated lotions and creams for the body, skin, face, and hands; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated skin care preparations; pharmaceutical preparations for treating epidermal problems
- Class 042 — Scientific and technological services: research and development of technology for biotechnology; scientific research in the fields of biomedicine; pharmaceutical products development; medical studies; medicine research; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; laboratory research in the field of biology; development of biologics; laboratory research in the field of gene expression; scientific research for medical purposes; research and development of amino acid for medical purposes; research and development of peptide for medical purposes; research and development of oligonucleotides for medical purposes; research and development of technology for medicinal chemical manufacturing
Owner
- IMNEWRUN, INC., SUWON-SI, GYEONGGI-DO, KR
- IMNEWRUN, INC., SUWON-SI, GYEONGGI-DO, KR
- IMNEWRUN, INC., SUWON-SI, GYEONGGI-DO, KR
- Imnewrun Biosciences, Inc., Suwon-si, Gyeonggi-do, KR
Prosecution history
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2024 — PUBLISHED FOR OPPOSITION
- 27 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jun 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Mar 2022 — ASSIGNED TO LIE
- 22 Mar 2022 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 08 Oct 2021 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 08 Oct 2021 — LETTER OF SUSPENSION E-MAILED
- 08 Oct 2021 — SUSPENSION LETTER WRITTEN
- 14 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED